首页 | 本学科首页   官方微博 | 高级检索  
检索        

联合检测血清CA125和CA72-4对卵巢癌诊断的价值
引用本文:黄文成,黄玲莎,赵惠柳,王英,朱波,李佩章.联合检测血清CA125和CA72-4对卵巢癌诊断的价值[J].海南医学,2005,16(7):152-153.
作者姓名:黄文成  黄玲莎  赵惠柳  王英  朱波  李佩章
作者单位:广西医科大学附属肿瘤医院,广西,南宁,530021
摘    要:目的探讨联合检测血清CA125和CA72-4的含量对卵巢癌的临床诊断的价值.方法卵巢癌患者58例、卵巢良性肿瘤患者48例及健康妇女50例的血清样品,用电化学发光免疫测定法测定CA125和CA72-4含量.结果与卵巢良性肿瘤组和健康妇女组相比,卵巢癌患者血清CA125和CA72-4的含量和阳性率明显升高(P<0.01),2项标志物的阳性率分别是79.3%和60.3%,联合检测阳性率为89.6%.结论联合检测CA125和CA72-4对卵巢癌的诊断具有重要临床价值.

关 键 词:卵巢癌  CA125  CA72-4  电化学发光
文章编号:1003-6350(2005)07-0152-02

The value of combined detection of serum CA125 and CA72-4 in the diagnosis of the ovarian carcinoma
HUANG Wen-cheng,HUANG Ling-sha,ZHAO Huiliu,et al.The value of combined detection of serum CA125 and CA72-4 in the diagnosis of the ovarian carcinoma[J].Hainan Medical Journal,2005,16(7):152-153.
Authors:HUANG Wen-cheng  HUANG Ling-sha  ZHAO Huiliu  
Abstract:Objective To study the value of combined detection of the serum levels of CA125 and CA72-4 in the diagnosis of the ovarian carcinoma. Methods Serum levels of CA125 and CA72-4 in 58 patients with ovarian carcinoma, 48 patients with benign ovarian tumor and 50 normal controls were measured by Elctrochemiluminescence immuno-assay (ECLIA). Results The levels of CA125 and CA72-4 in ovarian carcinoma group were significantly higher than those in benign ovarian tumor and normal control groups (P<0.01). Sensitivities of CA125 and CA72-4 were 79.3% and 60.3%, respectively. Sensitivity of combined detection of two kinds tumor markers was 89.6%. Conclusions The combined detection of CA125 and CA72-4 were of important clinical value in the ovarian carcinoma.
Keywords:Ovary cancer  CA125  CA72-4  ECLIA
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号